Annual EBITDA
-$2.75 M
-$859.60 K-45.36%
31 December 2023
Summary:
CytoMed Therapeutics Limited annual earnings before interest, taxes, depreciation & amortization is currently -$2.75 million, with the most recent change of -$859.60 thousand (-45.36%) on 31 December 2023. During the last 3 years, it has fallen by -$1.64 million (-147.02%). GDTC annual EBITDA is now -147.02% below its all-time high of -$1.12 million, reached on 01 December 2020.GDTC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GDTC EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -45.4% | - | - |
| 3 y3 years | -147.0% | - | - |
| 5 y5 years | - | - | - |
GDTC EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -147.0% | at low | ||||
| 5 y | 5 years | -147.0% | at low | ||||
| alltime | all time | -147.0% | at low |
CytoMed Therapeutics Limited EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$2.75 M(+45.4%) | - | - |
| Dec 2022 | -$1.90 M(+58.7%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$1.19 M(+7.1%) | - | - |
| Dec 2020 | -$1.12 M | - | - |
FAQ
- What is CytoMed Therapeutics Limited annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for CytoMed Therapeutics Limited?
- What is CytoMed Therapeutics Limited annual EBITDA year-on-year change?
What is CytoMed Therapeutics Limited annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of GDTC is -$2.75 M
What is the all time high annual EBITDA for CytoMed Therapeutics Limited?
CytoMed Therapeutics Limited all-time high annual earnings before interest, taxes, depreciation & amortization is -$1.12 M
What is CytoMed Therapeutics Limited annual EBITDA year-on-year change?
Over the past year, GDTC annual earnings before interest, taxes, depreciation & amortization has changed by -$859.60 K (-45.36%)